Does Bausch Health Companies Inc (BHC) Have What it Takes to be in Your Portfolio?

Friday, August 7, 2020 2:41 PM | InvestorsObserver Analysts

A rating of 89 puts Bausch Health Companies Inc (BHC) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Bausch Health Companies Inc's score of 89 means it scores higher than 89% of stocks in the industry. Bausch Health Companies Inc also received an overall rating of 58, putting it above 58% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 138 out of the 148 industries.

Overall Score - 58
BHC has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on BHC!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Bausch Health Companies Inc Stock Today?

Bausch Health Companies Inc (BHC) stock is lower by -9.74% while the S&P 500 is flat 0% as of 2:34 PM on Friday, Aug 7. BHC is lower by -$1.96 from the previous closing price of $20.13 on volume of 7,292,142 shares. Over the past year the S&P 500 has risen 13.99% while BHC is lower by -20.13%. BHC lost -$5.35 per share the over the last 12 months.

To see the top 5 stocks in Drug Manufacturers - Specialty & Generic click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Do Analysts Expect Inovio Pharmaceuticals Inc (INO) Stock to Rise?

Is Veeva Systems Inc (VEEV) The Right Choice in Health Information Services?

Is Evolus Inc (EOLS) a Winner in the Drug Manufacturers - Specialty & Generic Industry?

Is Pfenex Inc (PFNX) Stock Near the Top of the Biotechnology Industry?

How Will the Market React to Obseva SA (OBSV) Stock Getting a Bearish Rating

Should You Buy Moderna Inc (MRNA) Stock on Monday?

Related Companies